TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06647953: Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types

Sponsor: Children's Oncology Group · Phase: PHASE3 · Area: ONCOLOGY · Target Enrollment: 110 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$5,051,508

Rescue Site Savings

+$3,345,804

Unlock Full NCT06647953 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06647953 Rescue Dossier →